Logo1

Zastrozhin M, Skryabin V, Smirnov V, Grishina E, Ryzhikova K, Chumakov E, Sychev D, Bryun E.
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder.
Can J Physiol Pharmacol. 2019 May

скачать материал

17. doi: 10.1139/cjpp-2019-0177. [Epub ahead of print]

Mirzaev KB, Samsonova KI, Potapov PP, Andreev DA, Grishina EA, Ryzhikova KA, Sychev DA.
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel.
Mol Biol Rep. 2019 May 17.

 

doi: 10.1007/s11033-019-04871-y. [Epub ahead of print]

скачать материал

 

Zastrozhin MS., Sorokin AS., Agibalova AV., Grishina EA., Antonenko AР., Rozochkin IN., Duzhev DV., Skryabin VY., Galaktionova TE., Barna IV., Orlova AV., Aguzarov AD., Savchenko LM., Bryun EA., Sychev DA.
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Human Psychopharmacology: Clinical and Experimental.2018;e2677, 8.

скачать материал

 



DOI: 10.1002/hup.2677

Sychev DA, Abdullaev SP, Mirzaev KB, Ryzhikova KA, Shuyev GN, Sozaeva ZA, Grishina EA, Mammaev SN, Gafurov DM, Kitaeva EY, Shprakh VV, Suleymanov SS, Bolieva LZ, Sozaeva MS, Zhuchkova SM, Gimaldinova NE, Sidukova EE, Asoskova AV, Mumladze RB.
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
Mol Biol Rep. 2019 Mar 8. doi: 10.1007/s11033-019-04722-w. [Epub ahead of print]

 

скачать материал

 

Sychev D, Shikh N, Morozova T, Grishina E, Ryzhikova K, Malova E.
Effects of ABCB1 rs1045642 polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I–II hypertension.
Pharmacogenomics and Personalized Medicine 2018, 11:157-165.
DOI https://doi.org/10.2147/PGPM.S158401

 

скачать материал